Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sunshine Biopharma Inc.

1.35
+0.06004.65%
Post-market: 1.350.00000.00%19:40 EDT
Volume:887.55K
Turnover:1.21M
Market Cap:5.26M
PE:-0.18
High:1.48
Open:1.23
Low:1.23
Close:1.29
Loading ...
May 20, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
May 06, 2024

Major Issues Report

Form 8-K - Current report
Apr 23, 2024

Major Issues Report

Form 8-K - Current report
Apr 01, 2024

Major Issues Report

Form 8-K - Current report
Mar 28, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 06, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Major Issues Report

Form 8-K - Current report
Feb 23, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 21, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2024

Major Issues Report

Form 8-K - Current report
Feb 10, 2024

Correspondence

Form CORRESP - Correspondence
Feb 10, 2024

Correspondence

Form CORRESP - Correspondence
Feb 09, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 01, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 30, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans